AF

Amos Freud

R&d PET Products At Rotem Industries - Medical Imaging at Rotem Industries - Medical Imaging

Amos Freud is an experienced professional in the fields of quality assurance and research and development, currently serving as QA Manager at D.S. Bioanalytics since January 2017. Additionally, Amos Freud has held various roles at Rotem Industries from 2000 to the present, focusing on research and development of PET products for medical imaging, while also functioning as QA Manager. Academic credentials include a B.Pharm from The Hebrew University of Jerusalem, an M.Sc in Hormone Research from the Weizmann Institute of Science, and a Ph.D. in Biology from Ben-Gurion University of the Negev.

Location

Beersheba, Israel

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Rotem Industries - Medical Imaging

Hi-tech company specializing in the development and commercialization of technologies from research centers and start-ups. Rotem markets its products worldwide and has subsidiaries in the USA and Germany. Main business areas are medical imaging, crystal manufacturing, radiation detection and renewable energy. ​ Rotem Industries' Medical Imaging business is a world leader in consumables for PET imaging. Rotem develops, manufactures and supplies complete packages for the production of radiotracers: oxygen-18 enriched water, plastic cassettes, precursors and complete reagent kits for a range of synthesis modules. Rotem serves its customers through a global distribution network, and Rotem excels in uncompromising product quality coupled with a deep understanding of customer needs to ensure uniformly high production yields and unsurpassed quality. The passion for quality is driven by a team of highly skilled and dedicated professionals who recognize the critical role their products play in the PET radiotracer production chain. Rotem is very active in the development and production of consumables for new radiotracers under development. These projects benefit from our interdisciplinary expertise and direct market access, which is the result of years of direct, day-to-day, close collaboration with radiopharmaceutical companies worldwide.


Headquarters

Dimona, Israel

Employees

51-200

Links